Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration

被引:12
|
作者
Visser, Annemiek [1 ]
Vrieling, Alina [1 ]
Murugesu, Laxsini [2 ]
Hoogerbrugge, Nicoline [3 ]
Kampman, Ellen [1 ,4 ]
Hoedjes, Meeke [2 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands
[2] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands
[4] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
COLORECTAL-CANCER; LIFE-STYLE; HEALTH BEHAVIORS; RISK; GUIDELINES; MANAGEMENT; HNPCC;
D O I
10.1371/journal.pone.0178205
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Lynch Syndrome (LS) mutation carriers are at high risk for various cancer types, particularly colorectal cancer. Adherence to lifestyle and body weight recommendations for cancer prevention may lower this risk. To promote adherence to these recommendations, knowledge on determinants of adherence in LS mutation carriers is needed. Therefore, this study aimed to identify determinants of adherence to lifestyle recommendations for cancer prevention in LS mutation carriers. Methods Five focus groups were conducted with DNA confirmed LS mutation carriers (n = 29). Transcripts were analyzed by thematic analysis, using the Health Belief Model (HBM) as a theoretical framework. Results Tolerance of an unhealthy lifestyle because of the desire to enjoy life and avoidance of LS dominating their life were most frequently reported as important barriers of adherence to the recommendations. Most important facilitators of adherence to the recommendations were enhancement of wellbeing and intolerance of unhealthy foods due to colon surgery. Conclusions This study provided a comprehensive overview of determinants of adherence to recommendations for cancer prevention. These determinants, of which some are typically and unique for LS mutation carriers, can be used to design a lifestyle intervention that meets the needs of LS mutation carriers.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Increasing awareness and knowledge of lifestyle recommendations for cancer prevention in Lynch syndrome carriers: Randomized controlled trial
    Vrieling, A.
    Visser, A.
    Hoedjes, M.
    Hurks, M.
    Garcia, E. Gomez
    Hoogerbrugge, N.
    Kampman, E.
    CLINICAL GENETICS, 2018, 93 (01) : 67 - 77
  • [2] Determinants of adherence to recommendations on physical activity, red and processed meat intake, and body weight among lynch syndrome patients
    M Hoedjes
    A Vrieling
    L de Brauwer
    A Visser
    E Gómez García
    N Hoogerbrugge
    E Kampman
    Familial Cancer, 2023, 22 : 155 - 166
  • [3] Determinants of adherence to recommendations on physical activity, red and processed meat intake, and body weight among lynch syndrome patients
    Hoedjes, M.
    Vrieling, A.
    de Brauwer, L.
    Visser, A.
    Garcia, E. Gomez
    Hoogerbrugge, N.
    Kampman, E.
    FAMILIAL CANCER, 2023, 22 (02) : 155 - 166
  • [4] Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
    van der Post, R. S.
    Kiemeney, L. A.
    Ligtenberg, M. J. L.
    Witjes, J. A.
    Hulsbergen-van de Kaa, C. A.
    Bodmer, D.
    Schaap, L.
    Kets, C. M.
    van Krieken, J. H. J. M.
    Hoogerbrugge, N.
    JOURNAL OF MEDICAL GENETICS, 2010, 47 (07) : 464 - 470
  • [5] Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers
    Cuadros, Marta
    Cano, Carlos
    Garcia-Rodriguez, Sonia
    Martin, Jose Luis
    Poyatos-Andujar, Antonio
    Ruiz-Cabello, Francisco
    Pedrinaci, Susana
    Duran, Gema
    Benavides, Manuel
    Bautista-Ojeda, Maria Dolores
    Pereda, Teresa
    Benitez-Cantos, Maria Soledad
    Medina, Pedro
    Blanco, Armando
    Gonzalez, Antonio
    Lizardi, Paul
    BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [6] Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers
    Marta Cuadros
    Carlos Cano
    Sonia Garcia-Rodriguez
    José Luis Martín
    Antonio Poyatos-Andujar
    Francisco Ruiz-Cabello
    Susana Pedrinaci
    Gema Durán
    Manuel Benavides
    María Dolores Bautista-Ojeda
    Teresa Pereda
    Maria Soledad Benitez-Cantos
    Pedro Medina
    Armando Blanco
    Antonio Gonzalez
    Paul Lizardi
    BMC Medical Genomics, 15
  • [7] Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine
    Serrano, Davide
    Patrignani, Paola
    Stigliano, Vittoria
    Turchetti, Daniela
    Sciallero, Stefania
    Roviello, Franco
    D'Arpino, Alessandro
    Grattagliano, Ignazio
    Testa, Salvo
    Oliani, Cristina
    Bertario, Lucio
    Bonanni, Bernardo
    GENES, 2022, 13 (03)
  • [8] Preferences for breast cancer prevention among BRCA mutation carriers
    Jacobson, J.
    Patel, P.
    Bharthuar, A.
    Hershman, D.
    Hill, K.
    Warner, E.
    Plewes, D.
    Messner, S.
    Erichson, R.
    Grann, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers
    Etchegary, Holly
    Dicks, Elizabeth
    Watkins, Kathy
    Alani, Sabrina
    Dawson, Lesa
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2015, 13
  • [10] Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers
    Holly Etchegary
    Elizabeth Dicks
    Kathy Watkins
    Sabrina Alani
    Lesa Dawson
    Hereditary Cancer in Clinical Practice, 13